Stockreport

VNRX: Zacks SCR Refreshes its Latest Report With Volition's Financials, Prices, EPS Estimates, Market Statistics and Target Price Adjusted for 1-for-20 Reverse-Split [Yahoo! Finance]

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com
PDF VolitionRx's (NYSE: VNRX) Management's primary operational goal for 2026 continues to be securing licensing agreements for its Nu.Q assays for human diagnostic applicat [Read more]